# Bolt Biotherapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:839af13f-4847-4be6-a178-b529f6207475 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/bolt-biotherapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 19 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:53:41.002909+00:00 | | Last reviewed | 2026-10-16T13:53:41.002909+00:00 | ## Identity - Legal name: Bolt Biotherapeutics, Inc. - Display name: Bolt Biotherapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T01:40:06.577281+00:00 | | Completeness | 0.409 | | Record Quality | 0.834 | | Directors | 6 | | Committees | 5 | | Governance events | 11 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Brian O'Callaghan: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:5 - Jakob Dupont, M.D.: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:6 - Kathleen LaPorte: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:7 - Laura Berner: Director. Status: current. Independent: true. Since: 2022-01-01. Committees: Audit (member); Audit; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:8 - Nicole Onetto, M.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:9 - William P. Quinn: Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:10 ## Committees - Audit (audit). Chair: Kathleen LaPorte. Members: Kathleen LaPorte (chair, current); Laura Berner (member, current). committee_id=alpha:committee:bolt-biotherapeutics-inc:audit - Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: Kathleen LaPorte (member, current). committee_id=alpha:committee:bolt-biotherapeutics-inc:audit-chair-compensation - Audit; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Laura Berner (member, current). committee_id=alpha:committee:bolt-biotherapeutics-inc:audit-nominating-and-governance-chair - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Kathleen LaPorte (member, current). committee_id=alpha:committee:bolt-biotherapeutics-inc:compensation - Nominating and Governance (nominating_governance). Chair: Laura Berner. Members: Laura Berner (chair, current). committee_id=alpha:committee:bolt-biotherapeutics-inc:nominating-and-governance ## Executive leadership - Sarah Nemec: Senior Vice President, Finance. Status: current. claim_id=alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:11 - William P. Quinn: President, Chief Executive Officer and Chief Financial Officer [CEO]. Status: current. claim_id=alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:12 ## Governance events - EXECUTIVE_APPOINTED: Sarah Nemec executive of Bolt Biotherapeutics, Inc., effective 2026-03-12. Effective: 2026-03-12. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:vai8qa1pz7mfc - CEO_CHANGED: William P. Quinn executive of Bolt Biotherapeutics, Inc., effective 2026-03-12. Effective: 2026-03-12. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:cxdccuggjnki - DIRECTOR_APPOINTED: Jakob Dupont, M.D. seat on Bolt Biotherapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:14vsknfdcayf3 - DIRECTOR_APPOINTED: Laura Berner seat on Bolt Biotherapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:k6yzrj1uj353j - COMMITTEE_CREATED: Audit; Nominating and Governance · Chair committee of Bolt Biotherapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:12ok9b59uota3 - COMMITTEE_MEMBER_ADDED: Laura Berner member of Audit; Nominating and Governance · Chair, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:v7y90x12myrkp - DIRECTOR_APPOINTED: Brian O'Callaghan seat on Bolt Biotherapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:9fes2n2npmzp - DIRECTOR_APPOINTED: Nicole Onetto, M.D. seat on Bolt Biotherapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:suz0l11jl1px9 - DIRECTOR_APPOINTED: Kathleen LaPorte seat on Bolt Biotherapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:1flkluc94phl2 - COMMITTEE_CREATED: Audit · Chair; Compensation committee of Bolt Biotherapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:yhywtg1de1y9i - COMMITTEE_MEMBER_ADDED: Kathleen LaPorte member of Audit · Chair; Compensation, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:14io11ho6yxwv ## Scoped resources - `alpha://company/bolt-biotherapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record - `alpha://company/bolt-biotherapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=identity - `alpha://company/bolt-biotherapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=corporate-structure - `alpha://company/bolt-biotherapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=board - `alpha://company/bolt-biotherapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=committees - `alpha://company/bolt-biotherapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=leadership - `alpha://company/bolt-biotherapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=ownership - `alpha://company/bolt-biotherapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=financials - `alpha://company/bolt-biotherapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=capital-structure - `alpha://company/bolt-biotherapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=compensation - `alpha://company/bolt-biotherapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=governance - `alpha://company/bolt-biotherapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/bolt-biotherapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=audit - `alpha://company/bolt-biotherapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=legal - `alpha://company/bolt-biotherapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=risk - `alpha://company/bolt-biotherapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=cyber - `alpha://company/bolt-biotherapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=ai-governance - `alpha://company/bolt-biotherapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=agents - `alpha://company/bolt-biotherapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=ecosystem - `alpha://company/bolt-biotherapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=events - `alpha://company/bolt-biotherapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=relationships - `alpha://company/bolt-biotherapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=assessments - `alpha://company/bolt-biotherapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:kathleen-laporte","name":"Kathleen LaPorte"},"source_id":"board_seats"}` - Claim alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:laura-berner","name":"Laura Berner"},"source_id":"board_seats"}` - Claim alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:kathleen-laporte","name":"Kathleen LaPorte"},"source_id":"board_seats"}` - Claim alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:laura-berner","name":"Laura Berner"},"source_id":"board_seats"}` ## Leadership - Brian O'Callaghan: Director. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:5. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d. - Jakob Dupont, M.D.: Director. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:6. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d. - Kathleen LaPorte: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d. - Laura Berner: Director, Audit; Nominating and Governance · Chair. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:8. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d. - Nicole Onetto, M.D.: Director. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d. - William P. Quinn: Director. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d. - Sarah Nemec: Senior Vice President, Finance. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:11. Valid from: 2026-03-12. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:58c20d7717310668f09baa4b44806748d5f1a279efab2113219a3597af0f3366. - William P. Quinn: President, Chief Executive Officer and Chief Financial Officer. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:leadership_role:12. Valid from: 2026-03-12. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cbc4ae8ef667dcb810ba9d0421558abda09b08112a0d6bf9578d6b09eccd9710. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Kathleen LaPorte; Members Kathleen LaPorte (Chair); Laura Berner. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:committee_record:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:228d40de2b4aa5ece810568ce18bf0d4c54772ba15e0edc0fcb523aed0d411d2. - Compensation: Chair not stated; Members Kathleen LaPorte. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:228d40de2b4aa5ece810568ce18bf0d4c54772ba15e0edc0fcb523aed0d411d2. - Nominating and Governance: Chair Laura Berner; Members Laura Berner (Chair). Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:228d40de2b4aa5ece810568ce18bf0d4c54772ba15e0edc0fcb523aed0d411d2. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Bolt Biotherapeutics, Inc.. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:718e70aeef7005cdcd3ae963cfe0f3b31f392b6c9311bbcb5eb8f15b391cbb7e. ## Entity Status - Public listing published. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:718e70aeef7005cdcd3ae963cfe0f3b31f392b6c9311bbcb5eb8f15b391cbb7e. ## Published Fact - US. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:718e70aeef7005cdcd3ae963cfe0f3b31f392b6c9311bbcb5eb8f15b391cbb7e. ## Committee Appointment - Kathleen LaPorte: chair, Audit. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:228d40de2b4aa5ece810568ce18bf0d4c54772ba15e0edc0fcb523aed0d411d2. - Laura Berner: member, Audit. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:228d40de2b4aa5ece810568ce18bf0d4c54772ba15e0edc0fcb523aed0d411d2. - Kathleen LaPorte: member, Compensation. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:228d40de2b4aa5ece810568ce18bf0d4c54772ba15e0edc0fcb523aed0d411d2. - Laura Berner: chair, Nominating and Governance. Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:228d40de2b4aa5ece810568ce18bf0d4c54772ba15e0edc0fcb523aed0d411d2. ## Security Listing - BOLT (NASDAQ). Claim: alpha:claim:company:839af13f-4847-4be6-a178-b529f6207475:security_listing:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:718e70aeef7005cdcd3ae963cfe0f3b31f392b6c9311bbcb5eb8f15b391cbb7e. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:718e70aeef7005cdcd3ae963cfe0f3b31f392b6c9311bbcb5eb8f15b391cbb7e: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/bolt-biotherapeutics-inc). - alpha:projection-evidence:document:ce249426142b25a9d75a6fc8fea555525fe550eed5b683a2753a38943c5b576d: [Bolt Biotherapeutics, Inc. DEF 14A 2025-04-25](https://www.sec.gov/Archives/edgar/data/1641281/000095017025058632/bolt-20250425.htm). - alpha:projection-evidence:document:58c20d7717310668f09baa4b44806748d5f1a279efab2113219a3597af0f3366: [BOLT 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1641281/000119312526104121/bolt-20251231.htm). - alpha:projection-evidence:document:cbc4ae8ef667dcb810ba9d0421558abda09b08112a0d6bf9578d6b09eccd9710: [BOLT 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1641281/000119312526104121/bolt-20251231.htm). - alpha:projection-evidence:228d40de2b4aa5ece810568ce18bf0d4c54772ba15e0edc0fcb523aed0d411d2: [Audit](https://www.sec.gov/Archives/edgar/data/1641281/000095017025058632/bolt-20250425.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/bolt-biotherapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/bolt-biotherapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/bolt-biotherapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/bolt-biotherapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T01:40:06.373195+00:00; recorded 2026-10-17T01:40:06.373195+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.